Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2007 Jan 23.
Published in final edited form as: J Org Chem. 2005 Aug 5;70(16):6218–6221. doi: 10.1021/jo050518r

Synthesis of N-Fmoc-(2S,3S,4R)-3,4-dimethylglutamine. An Application of Lanthanide-Catalyzed Transamidation

Selçuk Çalimsiz 1, Mark A Lipton 1
PMCID: PMC1780274  NIHMSID: NIHMS10617  PMID: 16050680

Abstract

N-Fmoc-(2S,3S,4R)-3,4-dimethylglutamine (6) was synthesized from t-butyl N-Boc-(2S,3S,4R)-dimethylpyroglutamate (13). This synthesis involved selective deprotection of a Boc group from a lactam nitrogen in the presence of a t-butyl ester, Fmoc protection of the lactam, and a lanthanide-catalyzed transamidation reaction of the Fmoc-protected lactam using ammonia and dimethylaluminum chloride. The scope of Lewis acid-catalyzed transamidation of acylated lactams was explored through the variation of lanthanide, lactam, acyl group, amine and aluminum reagent. The reactivity of various metal triflates was found to vary in the qualitative order: Yb∼Sc>Er∼Eu∼Sm>Ce∼AgI>CuII∼Zn. Intriguingly, catalysis was only observed when ammonia was the nitrogen nucleophile; addition of other amidoaluminum complexes to acyl lactams was found to be insensitive to the addition of lanthanides.

Keywords: lanthanide, catalysis, transamidation, callipeltin, papuamide

Introduction

The non-proteinogenic amino acid (2S,3R,4S)-3,4-dimethylglutamine (DiMeGln) has been found to be a key component of the cyclic depsipeptide natural products callipeltin A1 (1) and papuamides A (2) and B (3).2 Callipeltin A (1) was isolated from a shallow water sponge of the genus Callipelta (order Lithistida) by Minale and coworkers and shown to have both antitumor and anti HIV activities.1 Likewise, the papuamides were isolated from the sponges Theonella mirabilis and Theonella swinhoe by Boyd and coworkers and shown to also possess both antitumor and anti-HIV activities.2

To date, syntheses of DiMeGln have been reported by Joullié,3 Hamada,4, and ourselves.5 In all three cases, however DiMeGln was synthesized with acid-labile protecting groups on Nα. In our case, an Fmoc-protected version of DiMeGln was desired for an Fmoc-based solid phase synthesis of 1, 2 and related molecules. However, when the Boc-protected intermediate 4 was deprotected and reprotected with an Fmoc group under Schotten-Baumann conditions, it was found that the product 5 was a mixture of C-4 epimers, presumably as a result of acid-catalyzed enolization of the side chain amide (Scheme 1).6 Variation of the deprotection conditions failed to alleviate this problem, so an alternate solution was sought.

Scheme 1.

Scheme 1

Results and Discussion

Our revised strategy to obtain the Fmoc-protected DiMeGln residue 6 (Scheme 2) called for ammonolysis of an Fmoc-protected lactam 7 that would be synthesized from the previously synthesized intermediate 8 via selective Boc deprotection of the lactam nitrogen in the presence of the t-butyl ester followed by Fmoc protection of the lactam nitrogen.

Scheme 2.

Scheme 2

The model compound 9 (Scheme 3) was selected for its ready accessibility from commercially available (S)-pyroglutamic acid.7,8 Extensive exploration revealed two methods for selective deprotection of the lactam (Scheme 3). In the first method, microwave irradiation of 9 on silica support for 1 minute9 gave the desired product 10 in 35-75% yield. Alternatively, catalytic Yb(OTf)3 in THF effectively deprotected 9 after 18 hours,10 giving 10 in quantitative yield. Despite the quicker reaction time and easier workup of the microwave deprotection method, deprotection with Yb(OTf)3 was adopted as the method of choice owing to variability in yields using microwave radiation.

Scheme 3.

Scheme 3

Scheme 4.

Scheme 4

The next step in the synthesis called for Fmoc protection of a lactam nitrogen. This was accomplished by deprotonation of the amide nitrogen of 10 LHMDS at -78°C, followed by inverse addition of the deprotonated amide into 5 equivalents of Fmoc-Cl (Scheme 4). This procedure gave the desired product, 11, in 76% isolated yield after 14 h.

Scheme 5.

Scheme 5

In the next step, 11 was subjected to the ammonolysis conditions that had previously worked successfully with its Boc-protected analogue, 8.5 To our surprise, reaction of 11 with AlMe3-NH311 gave only 38% of the desired product 12 and after 2 hours led to substantial deprotection of the Fmoc group. It was inferred from these results that the reagent was basic enough to deprotect an Fmoc carbamate. It was reasoned that, to avoid Fmoc deprotection, a faster or less basic ammonolysis reaction was needed. To this end, the use of Lewis acids as catalysts was investigated. In an early screening experiment, it was discovered that addition of catalytic Yb(OTf)3 catalyzes ammonolysis of 11 by AlMe3-NH3 very efficiently (Scheme 5). After optimization studies it was determined that usage of 6-10 equivalents of AlMe3, addition of 40 mol% lanthanide catalyst, and changing the solvent from CH2Cl2 to THF were needed to obtain high yields.

Scheme 6.

Scheme 6

Under these conditions, ammonolysis of 11 was nearly instantaneous even at 25°C. On the basis of these encouraging results, other Lewis acidic metal triflates - Sc(OTf)3, Er(OTf)3, Eu(OTf)3, Sm(OTf)3 Ce(OTf)3, Ag(OTf), Cu(OTf)2, and Zn(OTf)2 - were also screened as potential catalysts of ammonolysis (Table 1). As expected, Sc(OTf)3 was as reactive as Yb(OTf)3 and both proved to be the most active Lewis acid catalysts tested. Although Er(OTf)3, Eu(OTf)3 and Sm(OTf)3 gave slower reactions that went to completion in 5 minutes, reaction with Eu(OTf)3 and Sm(OTf)3 resulted in the production of fewer side products. The use of Ce(OTf)3, Ag(OTf), Cu(OTf)2 and Zn(OTf)2 as catalysts resulted in slower reactions that were complete in 20-30 minutes with moderate yields (Table 1). In the best cases, the yield of ammonolysis product was improved and the time of reaction drastically reduced. It was also noted that the amount of Fmoc deprotection observed in these reactions was substantially less than in the uncatalyzed version. Whether the decrease in Fmoc deprotection results from lessened basicity of the reagent or is simply a result of the much shorter reaction times we cannot determine.

Table 1.

Lewis Acid Catalysis of Transamidation

graphic file with name nihms-10617-0009.jpg
Catalysta Time, min Yield, %
- 120 38
Yb(OTf)3 2 87
Sc(OTf)3 2 88
Er(OTf)3 5 78
Eu(OTf)3 5 91
Sm(OTf)3 5 91
Ce(OTf)3 20 70
Ag(OTf) 20 36
Cu(OTf)2 30 24
Zn(OTf)2 30 67
a

40 mol % used.

It has also recently been shown that the use of Me2AlCl/NH3 affords greater reactivity than AlMe3/NH3 for the ammonolysis of sterically demanding esters.12 All the metal triflates mentioned above were also screened with Me2AlCl instead of AlMe3. Although the reactivity trend was almost the same, and yields were slightly better (see Table 2), reactions with Me2AlCl were slower their AlMe3 counterparts.

Table 2.

Lanthanide catalyzed transamidation of Lactams

Amine Lactam Al reagent Catalysta Time, min Yield, %
NH3 7 AlMe3 - 120 61
NH3 7 AlMe3 Yb(OTf)3 10 32
NH3 7 Me2AlCl - 120 25
NH3 7 Me2AlCl Eu(OTf)3 30 77
NH3 11 AlMe3 - 120 38
NH3 11 AlMe3 Yb(OTf)3 2 87
NH3 11 Me2AlCl Eu(OTf)3 10 91
NH3 16 AlMe3 - 60 40
NH3 16 Me2AlCl Eu(OTf)3 60 90
NH3 9 AlMe3 - 10 85
NH3 9 AlMe3 Yb(OTf)3 10 86
PhCH2NH2 11 AlMe3 - 5 80
PhCH2NH2 11 AlMe3 Yb(OTf)3 10 80
PhCH2NH2 11 Me2AlCl Eu(OTf)3 40 87
Et2NH 11 AlMe3 - 180 b
Et2NH 11 AlMe3 Yb(OTf)3 60 b
t-BuNH2 11 AlMe3 - 360 c
t-BuNH2 11 AlMe3 Yb(OTf)3 360 c
a

40 mol %

b

Fmoc deprotection

c

Partial Fmoc deprotection.

With the methodology in hand, our efforts turned to the synthesis of the desired product 6, beginning with the conversion of the previously synthesized intermediate 13 to its t-butyl ester 8 using N,N'-diisopropyl-O-tert-butylisourea.5 Selective deprotection of the lactam Boc group with catalytic Yb(OTf)3 gave the lactam 14, which was then protected with an Fmoc group in high yield. Ring opening of the Fmoc-protected lactam 7 using ammonia in conjunction with Me2AlCl and Eu(OTf)3 resulted in the formation of 15 in 77% isolated yield. The target compound 6 was obtained from 15 by treatment with TFA in methylene chloride in high yield. In contrast to our previous efforts, the 1H-NMR of 6 showed no evidence of epimerization.

With the synthesis of 6 thus completed, it was decided to further investigate the scope of lanthanide catalyzed transamidation by examining the reaction of N-Fmoc-caprolactam (16) in addition to 7 and 11 (Table 2).

Except in the case of 7, lanthanide-catalyzed ammonolysis of Fmoc-protected lactams (7, 11 and 16) gave higher yields and shorter reaction times compared to the uncatalyzed reactions. In addition to the Fmoc-protected lactams, Boc-protected lactam 9, was also subjected to ammonolysis reaction conditions. Interestingly, even with the NH3 no significant catalytic activity by the addition of metal triflates was observed. Amines other than NH3 were also tried with 11, but in no case was catalysis by the added lanthanide triflate observed.

Conclusion

In summary, N-Fmoc-(2S,3S,4R)-3,4-dimethylglutamine (6) was synthesized in 57% overall yield in five steps starting from t-butyl N-Boc-(2S,3S,4R)-3,4-dimethylpyroglutamate (13). It was also shown that lanthanide triflates catalyze the ammonolysis of Fmoc-protected lactams in conjunction with AlMe3 or Me2AlCl. These conditions offer a way to ammonolyze even sterically hindered, Fmoc-protected lactams. With compound 6 in hand, total syntheses of the callipeltins and papuamides are actively under way.

Experimental Section

General Procedure for Boc deprotection of Lactams with Catalytic Yb(OTf)3.

To a solution of Boc protected lactam in THF (2 ml) Yb(OTf)3 (45 mol %) was added. The mixture was stirred at rt for 18 hours and the solvent was removed under reduced pressure. The residue was diluted with CH2Cl2 (2 ml) and solution filtered through a fine proze funnel. The filtrate was concentrated under reduced pressure. The crude was purified by flash chromatography on silica gel.

t-butyl (2S,3S,4R)-3,4-dimethylpyroglutamate (14). The general procedure for Boc deprotection of lactam was followed using t-butyl N-Boc-(2S,3S,4R)-3,4-dimethylpyroglutamate (8) (89.3 mg, 0.285 mmol) and Yb(OTf)3 (70.71 mg, 0.114 mmol). Flash column chromatography with 50% EtOAc/petroleum ether yielded 14 as a colorless, flocculent crystalline solid (57.4 mg, 95%): mp 61°C; IR (NaCl, cm-1) 3233 (br), 2975, 2934, 2871, 1735, 1709, 1458, 1393, 1219, 1158; 1H NMR (300 MHz, CDCl3) δ 5.78 (bs, 1H), 3.67 (d, 1H, 4.7Hz), 2.64-2.53 (m, 2H), 1.49 (s, 9H), 1.16 (d, 3H, 6.74Hz), 1.11 (d, 3H, 7.18Hz) ppm; 13C NMR (75 MHz, CDCl3) δ 179.7, 170.9, 82.4, 61.4, 39.1, 37.8, 28, 14.6, 10.4 ppm; HRMS (CI) calcd for C11H19NO3 (M+) 214.1443, found 214.1446.

General procedure for the Fmoc protection of lactams.

To a solution of the lactam in THF at -78°C LHMDS (0.95 eq, 1M solution in THF) was added slowly. The resultant pale yellow mixture was stirred at -78°C for 15 minutes, and slowly transferred by cannula to a solution of Fmoc-Cl (5 eq) in THF at -78°C. The reaction was allowed to stir at -78°C for 2 hours, after which it was allowed to rise to room temperature. After 14 hours stirring at room temperature, the reaction was quenched by addition of sat. NH4Cl (2 ml) and H2O (1 ml). The solution was extracted with EtOAc and washed with brine. The organic phase was dried over Na2SO4 and concentrated under reduced pressure. The crude product was purified by flash column chromatography.

t-butyl N-Fmoc-(2S,3S,4R)-3,4-dimethylpyroglutamate (7). The general procedure for Fmoc protection of lactam was followed using t-butyl (2S,3S,4R)-3,4-dimethylpyroglutamate (14) (27 mg, 0.127 mmol) in THF (2 ml). Flash column chromatography with 20% EtOAc/petroleum ether yielded 7 as a colorless oil (48 mg, 87%): IR (NaCl, cm-1) 3066, 2977, 2935, 2978, 1798, 1761, 1722, 1478, 1451, 1387, 1369, 1303, 1156; 1H NMR (300 MHz, CDCl3) δ 7.75 (d, 4H, 7.6Hz), 7.41-7.24 (m, 4H), 4.55-4.3 (m, 3H), 4.14 (s, 1H), 2.85 (p, 1H, 7Hz), 2.50 (p, 1H, 7Hz), 1.44 (s, 9H), 1.16 (d, 3H, 7Hz), 1.10 (d, 3H, 7Hz) ppm; 13C NMR (75 MHz, CDCl3) δ 174.9, 169.6, 151.9, 143.6 143.4, 141.3, 141.2, 127.8, 127.3, 125.5, 119.9, 82.6, 69, 64.9, 46.7, 40.7, 34.7, 27.9, 15.4, 9.9 ppm; HRMS (ESI) calcd for C26H29NO5 (Na+) 458.1943, found 458.1945.

t-Butyl Nα-Fmoc-(2S,3S,4R)-3,4-dimethylglutamine (15). To a solution of Me2AlCl (2.52 ml, 2.52 mmol) in CH2Cl2 (4 ml) at -8°C was bubbled gaseous NH3 for 4 min. The reaction was allowed to stir at -8°C for 15 minutes and allowed to warm to room temperature. Over 30 minutes CH2Cl2 was removed using a flow of nitrogen gas to afford a colorless slurry. The residue was added THF (7 ml), and let it stir at 25°C for a minute. Then lactam 7 (109.8 mg, 0.252 mmol) and Eu(OTf)3 (60.4 mg, 0.1008 mmol) in THF (1.1 ml) was added. After 30 min reaction was quenched using 0.1 N HCl (25.2 ml, 2.52 mmol) and EtOAc (10 ml). The solution was then extracted with EtOAc (3×10 ml). Organic fractions were combined, washed with brine (3×10 ml) and dried over Na2SO4. After removal of solvent under reduced pressure the crude product was purified by flash column chromatography with 50% EtOAc/hexane followed by 80% EtOAc/hexane yielded 15 as a colorless oil (88 mg, 77%): IR (NaCl, cm-1) 3345 (br), 3203, 3066, 2975, 2936, 1716, 1662, 1516, 1452, 1427, 1369, 1345, 1156; 1H NMR (300 MHz, CDCl3) δ 7.79-7.76 (m, 2H), 7.60 (d, 2H, 7Hz), 7.45-7.27 (m, 4H), 6.83 (br, 1H), 5.64 (d, 1H, 8.8Hz), 5.57 (br, 1H), 4.60-4.55 (m, 1H), 4.46-4.40 (m, 1H), 4.25-4.17 (m, 1H), 2.37 (dd, 1H, 6.5-3.5Hz), 1.82 (br, 1H), 1.49 (s, 9H), 1.16 (d, 3H, 7Hz), 0.94 (d, 3H, 7Hz) ppm; 13C NMR (75 MHz, CDCl3) δ 175.9, 170.7, 156.8, 143.7, 143.4, 141.4, 141.3, 127.8, 127.1, 125.0, 124.9, 120.0, 119.9, 82.9, 66.9, 57.6, 47.3, 41.6, 40.0, 27.9, 16.1, 12.4 ppm; HRMS (ESI) calcd for C26H32N2O5 (Na+) 475.2209, found 475.2213.

N-Fmoc-(2S,3S,4R)-3,4-dimethylglutamine (6). A solution of t-Butyl N-Fmoc-(2S,3S,4R)-3,4-dimethylglutamine (15) (88 mg, 0.195 mmol) in 30%TFA-CH2Cl2 (1.5 ml) was allowed to stir at room temperature for 90 min. Removal of solvent and TFA by evaporation under reduced pressure yielded N-Fmoc-(2S,3S,4R)-3,4-dimethylglutamine (6) as a fine, colorless powder (71.7 mg, 93%): mp: decomposition >210°C;IR (NaCl, cm-1) 3323 (br), 3066, 2923, 2851, 1702, 1671, 1609, 1515, 1450, 1412, 1319, 1227, 1034; 1H NMR (300 MHz, C2D6SO) δ 7.89 (d, 2H, 7.6Hz), 7.75 (d, 2H, 6.5), 7.44-7.33 (4H, m), 6.82 (s, 1H), 4.25 (bs, 3H), 4.15 (m, 1H), 2.34 (t, 1H, 7Hz), 1.97 (bs, 1H), 1.42 (s, 1H), 1.09 (d, 3H, 6.4Hz), 0.87 (d, 3H, 5.9Hz) ppm; 13C NMR (75 MHz, C2D6SO) δ 181, 174.5, 158.7, 145.5, 145.3, 142.7, 128.3, 126.5, 126.3, 121.2, 121.1, 68.2, 57.4, 48.3, 44.0, 40.5, 16.9, 10.5 ppm; HRMS (ESI) calcd for C22H24N2O5 (Na+) 419.1583, found 419.1583.

Supplementary Material

2
3

Figure 1.

Figure 1

Callipeltin A (1).

Figure 2.

Figure 2

Papuamides A (2) and B (3).

Acknowledgments

Acknowledgment. We thank the National Institutes of Health (AI-50888) for financial support of this work.

Footnotes

Supporting Information Avaliable: Complete experimental descriptions of transformations not included in the Experimental Section and characterization for all new compounds. This material is available free of charge via the Internet at http://pubs.acs.org.

References

  • 1.Zampella A, D’auria MV, Paloma LG, Casapullo A, Minale L, Debitus C, Henin Y. J. Am. Chem. Soc. 1996;118:6202. [Google Scholar]
  • 2.Ford PW, Gustafson KR, McKee TC, Shigematsu N, Maurizi LK, Pannell LK, Williams DE, de Silva ED, Lassota P, Allen TM, Van Soest R, Andersen RJ, Boyd MR. J. Am. Chem. Soc. 1999;121:5899. [Google Scholar]
  • 3.Liang B, Carroll PJ, Joullié MM. Org. Lett. 2000;2:4157. doi: 10.1021/ol006679t. [DOI] [PubMed] [Google Scholar]
  • 4.Okamoto N, Hara O, Makino K, Hamada Y. Tetrahedron Asym. 2001;12:1353. [Google Scholar]
  • 5.Acevedo CM, Kogut EF, Lipton MA. Tetrahedron. 2001;57:6353. [Google Scholar]
  • 6.Acevedo CM. Purdue University, West Lafayette: May, 2004. Ph.D. [Google Scholar]
  • 7.Kolasa T, Miller MJ. J. Org. Chem. 1990;55:1711. [Google Scholar]
  • 8.August RA, Khan JA, Moody CM, Young DW. J. Chem. Soc. Perkin Trans. 1996:507. [Google Scholar]
  • 9.Siro JG, Martín J, García-Navío JL, Remuiňan MJ, Vaquero JV. Synlett. 1998:147. [Google Scholar]
  • 10.(a) Kotsuki H, Ohishi T, Araki T, Arimura K. Tetrahedron Lett. 1998;39:4869. [Google Scholar]; (b) Evans DA, Trotter BW, Coleman PJ, Côté B, Dias LC, Rajapakse HA, Tyler AN. Tetrahedron. 1999;55:8671–8726. [Google Scholar]; (c) Vanderwal CD, Jacobsen EN. J. Am. Chem. Soc. 2004;126:14724–14725. doi: 10.1021/ja045563f. [DOI] [PubMed] [Google Scholar]
  • 11.Basha A, Lipton M, Weinreb SM. Tetrahedron Lett. 1977;18:4171. [Google Scholar]
  • 12.Shimizu T, Osako K, Nakata T. Tetrahedron Lett. 1997;38:2685. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

2
3

RESOURCES